Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Medicine market report explains the definition, types, applications, major countries, and major players of the Medicine market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Shire
Novartis
Gilead Sciences
Bristol-Myers Squibb
Roche
Pfizer
AstraZeneca
AbbVie
Novo Nordisk
Bayer
Merck & Co (MSD)
GlaxoSmithKline (GSK)
Teva
Amgen
Eli Lilly
Takeda
Boehringer Ingelheim
Allergan
Sanofi
Johnson & Johnson
By Type:
Brand Drugs
Generic Drug
By End-User:
Hospital
Clinic
Other
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Medicine Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Medicine Outlook to 2028- Original Forecasts
-
2.2 Medicine Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Medicine Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Medicine Market- Recent Developments
-
6.1 Medicine Market News and Developments
-
6.2 Medicine Market Deals Landscape
7 Medicine Raw Materials and Cost Structure Analysis
-
7.1 Medicine Key Raw Materials
-
7.2 Medicine Price Trend of Key Raw Materials
-
7.3 Medicine Key Suppliers of Raw Materials
-
7.4 Medicine Market Concentration Rate of Raw Materials
-
7.5 Medicine Cost Structure Analysis
-
7.5.1 Medicine Raw Materials Analysis
-
7.5.2 Medicine Labor Cost Analysis
-
7.5.3 Medicine Manufacturing Expenses Analysis
8 Global Medicine Import and Export Analysis (Top 10 Countries)
-
8.1 Global Medicine Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Medicine Export by Region (Top 10 Countries) (2017-2028)
9 Global Medicine Market Outlook by Types and Applications to 2022
-
9.1 Global Medicine Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Brand Drugs Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Generic Drug Consumption and Growth Rate (2017-2022)
-
9.2 Global Medicine Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Other Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Medicine Market Analysis and Outlook till 2022
-
10.1 Global Medicine Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Medicine Consumption (2017-2022)
-
10.2.2 Canada Medicine Consumption (2017-2022)
-
10.2.3 Mexico Medicine Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Medicine Consumption (2017-2022)
-
10.3.2 UK Medicine Consumption (2017-2022)
-
10.3.3 Spain Medicine Consumption (2017-2022)
-
10.3.4 Belgium Medicine Consumption (2017-2022)
-
10.3.5 France Medicine Consumption (2017-2022)
-
10.3.6 Italy Medicine Consumption (2017-2022)
-
10.3.7 Denmark Medicine Consumption (2017-2022)
-
10.3.8 Finland Medicine Consumption (2017-2022)
-
10.3.9 Norway Medicine Consumption (2017-2022)
-
10.3.10 Sweden Medicine Consumption (2017-2022)
-
10.3.11 Poland Medicine Consumption (2017-2022)
-
10.3.12 Russia Medicine Consumption (2017-2022)
-
10.3.13 Turkey Medicine Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Medicine Consumption (2017-2022)
-
10.4.2 Japan Medicine Consumption (2017-2022)
-
10.4.3 India Medicine Consumption (2017-2022)
-
10.4.4 South Korea Medicine Consumption (2017-2022)
-
10.4.5 Pakistan Medicine Consumption (2017-2022)
-
10.4.6 Bangladesh Medicine Consumption (2017-2022)
-
10.4.7 Indonesia Medicine Consumption (2017-2022)
-
10.4.8 Thailand Medicine Consumption (2017-2022)
-
10.4.9 Singapore Medicine Consumption (2017-2022)
-
10.4.10 Malaysia Medicine Consumption (2017-2022)
-
10.4.11 Philippines Medicine Consumption (2017-2022)
-
10.4.12 Vietnam Medicine Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Medicine Consumption (2017-2022)
-
10.5.2 Colombia Medicine Consumption (2017-2022)
-
10.5.3 Chile Medicine Consumption (2017-2022)
-
10.5.4 Argentina Medicine Consumption (2017-2022)
-
10.5.5 Venezuela Medicine Consumption (2017-2022)
-
10.5.6 Peru Medicine Consumption (2017-2022)
-
10.5.7 Puerto Rico Medicine Consumption (2017-2022)
-
10.5.8 Ecuador Medicine Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Medicine Consumption (2017-2022)
-
10.6.2 Kuwait Medicine Consumption (2017-2022)
-
10.6.3 Oman Medicine Consumption (2017-2022)
-
10.6.4 Qatar Medicine Consumption (2017-2022)
-
10.6.5 Saudi Arabia Medicine Consumption (2017-2022)
-
10.6.6 United Arab Emirates Medicine Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Medicine Consumption (2017-2022)
-
10.7.2 South Africa Medicine Consumption (2017-2022)
-
10.7.3 Egypt Medicine Consumption (2017-2022)
-
10.7.4 Algeria Medicine Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Medicine Consumption (2017-2022)
-
10.8.2 New Zealand Medicine Consumption (2017-2022)
11 Global Medicine Competitive Analysis
-
11.1 Shire
-
11.1.1 Shire Company Details
-
11.1.2 Shire Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Shire Medicine Main Business and Markets Served
-
11.1.4 Shire Medicine Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Novartis
-
11.2.1 Novartis Company Details
-
11.2.2 Novartis Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Novartis Medicine Main Business and Markets Served
-
11.2.4 Novartis Medicine Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Gilead Sciences
-
11.3.1 Gilead Sciences Company Details
-
11.3.2 Gilead Sciences Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Gilead Sciences Medicine Main Business and Markets Served
-
11.3.4 Gilead Sciences Medicine Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Bristol-Myers Squibb
-
11.4.1 Bristol-Myers Squibb Company Details
-
11.4.2 Bristol-Myers Squibb Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Bristol-Myers Squibb Medicine Main Business and Markets Served
-
11.4.4 Bristol-Myers Squibb Medicine Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Roche
-
11.5.1 Roche Company Details
-
11.5.2 Roche Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Roche Medicine Main Business and Markets Served
-
11.5.4 Roche Medicine Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Pfizer
-
11.6.1 Pfizer Company Details
-
11.6.2 Pfizer Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Pfizer Medicine Main Business and Markets Served
-
11.6.4 Pfizer Medicine Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 AstraZeneca
-
11.7.1 AstraZeneca Company Details
-
11.7.2 AstraZeneca Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 AstraZeneca Medicine Main Business and Markets Served
-
11.7.4 AstraZeneca Medicine Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 AbbVie
-
11.8.1 AbbVie Company Details
-
11.8.2 AbbVie Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 AbbVie Medicine Main Business and Markets Served
-
11.8.4 AbbVie Medicine Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Novo Nordisk
-
11.9.1 Novo Nordisk Company Details
-
11.9.2 Novo Nordisk Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Novo Nordisk Medicine Main Business and Markets Served
-
11.9.4 Novo Nordisk Medicine Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 Bayer
-
11.10.1 Bayer Company Details
-
11.10.2 Bayer Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 Bayer Medicine Main Business and Markets Served
-
11.10.4 Bayer Medicine Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 Merck & Co (MSD)
-
11.11.1 Merck & Co (MSD) Company Details
-
11.11.2 Merck & Co (MSD) Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 Merck & Co (MSD) Medicine Main Business and Markets Served
-
11.11.4 Merck & Co (MSD) Medicine Product Portfolio
-
11.11.5 Recent Research and Development Strategies
-
11.12 GlaxoSmithKline (GSK)
-
11.12.1 GlaxoSmithKline (GSK) Company Details
-
11.12.2 GlaxoSmithKline (GSK) Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
11.12.3 GlaxoSmithKline (GSK) Medicine Main Business and Markets Served
-
11.12.4 GlaxoSmithKline (GSK) Medicine Product Portfolio
-
11.12.5 Recent Research and Development Strategies
-
11.13 Teva
-
11.13.1 Teva Company Details
-
11.13.2 Teva Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
11.13.3 Teva Medicine Main Business and Markets Served
-
11.13.4 Teva Medicine Product Portfolio
-
11.13.5 Recent Research and Development Strategies
-
11.14 Amgen
-
11.14.1 Amgen Company Details
-
11.14.2 Amgen Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
11.14.3 Amgen Medicine Main Business and Markets Served
-
11.14.4 Amgen Medicine Product Portfolio
-
11.14.5 Recent Research and Development Strategies
-
11.15 Eli Lilly
-
11.15.1 Eli Lilly Company Details
-
11.15.2 Eli Lilly Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
11.15.3 Eli Lilly Medicine Main Business and Markets Served
-
11.15.4 Eli Lilly Medicine Product Portfolio
-
11.15.5 Recent Research and Development Strategies
-
11.16 Takeda
-
11.16.1 Takeda Company Details
-
11.16.2 Takeda Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
11.16.3 Takeda Medicine Main Business and Markets Served
-
11.16.4 Takeda Medicine Product Portfolio
-
11.16.5 Recent Research and Development Strategies
-
11.17 Boehringer Ingelheim
-
11.17.1 Boehringer Ingelheim Company Details
-
11.17.2 Boehringer Ingelheim Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
11.17.3 Boehringer Ingelheim Medicine Main Business and Markets Served
-
11.17.4 Boehringer Ingelheim Medicine Product Portfolio
-
11.17.5 Recent Research and Development Strategies
-
11.18 Allergan
-
11.18.1 Allergan Company Details
-
11.18.2 Allergan Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
11.18.3 Allergan Medicine Main Business and Markets Served
-
11.18.4 Allergan Medicine Product Portfolio
-
11.18.5 Recent Research and Development Strategies
-
11.19 Sanofi
-
11.19.1 Sanofi Company Details
-
11.19.2 Sanofi Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
11.19.3 Sanofi Medicine Main Business and Markets Served
-
11.19.4 Sanofi Medicine Product Portfolio
-
11.19.5 Recent Research and Development Strategies
-
11.20 Johnson & Johnson
-
11.20.1 Johnson & Johnson Company Details
-
11.20.2 Johnson & Johnson Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
11.20.3 Johnson & Johnson Medicine Main Business and Markets Served
-
11.20.4 Johnson & Johnson Medicine Product Portfolio
-
11.20.5 Recent Research and Development Strategies
12 Global Medicine Market Outlook by Types and Applications to 2028
-
12.1 Global Medicine Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Brand Drugs Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Generic Drug Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Medicine Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Medicine Market Analysis and Outlook to 2028
-
13.1 Global Medicine Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Medicine Consumption Forecast (2022-2028)
-
13.2.2 Canada Medicine Consumption Forecast (2022-2028)
-
13.2.3 Mexico Medicine Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Medicine Consumption Forecast (2022-2028)
-
13.3.2 UK Medicine Consumption Forecast (2022-2028)
-
13.3.3 Spain Medicine Consumption Forecast (2022-2028)
-
13.3.4 Belgium Medicine Consumption Forecast (2022-2028)
-
13.3.5 France Medicine Consumption Forecast (2022-2028)
-
13.3.6 Italy Medicine Consumption Forecast (2022-2028)
-
13.3.7 Denmark Medicine Consumption Forecast (2022-2028)
-
13.3.8 Finland Medicine Consumption Forecast (2022-2028)
-
13.3.9 Norway Medicine Consumption Forecast (2022-2028)
-
13.3.10 Sweden Medicine Consumption Forecast (2022-2028)
-
13.3.11 Poland Medicine Consumption Forecast (2022-2028)
-
13.3.12 Russia Medicine Consumption Forecast (2022-2028)
-
13.3.13 Turkey Medicine Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Medicine Consumption Forecast (2022-2028)
-
13.4.2 Japan Medicine Consumption Forecast (2022-2028)
-
13.4.3 India Medicine Consumption Forecast (2022-2028)
-
13.4.4 South Korea Medicine Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Medicine Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Medicine Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Medicine Consumption Forecast (2022-2028)
-
13.4.8 Thailand Medicine Consumption Forecast (2022-2028)
-
13.4.9 Singapore Medicine Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Medicine Consumption Forecast (2022-2028)
-
13.4.11 Philippines Medicine Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Medicine Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Medicine Consumption Forecast (2022-2028)
-
13.5.2 Colombia Medicine Consumption Forecast (2022-2028)
-
13.5.3 Chile Medicine Consumption Forecast (2022-2028)
-
13.5.4 Argentina Medicine Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Medicine Consumption Forecast (2022-2028)
-
13.5.6 Peru Medicine Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Medicine Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Medicine Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Medicine Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Medicine Consumption Forecast (2022-2028)
-
13.6.3 Oman Medicine Consumption Forecast (2022-2028)
-
13.6.4 Qatar Medicine Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Medicine Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Medicine Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Medicine Consumption Forecast (2022-2028)
-
13.7.2 South Africa Medicine Consumption Forecast (2022-2028)
-
13.7.3 Egypt Medicine Consumption Forecast (2022-2028)
-
13.7.4 Algeria Medicine Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Medicine Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Medicine Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Medicine
-
Figure of Medicine Picture
-
Table Global Medicine Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Medicine Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Brand Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Generic Drug Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Clinic Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Medicine Consumption by Country (2017-2022)
-
Table North America Medicine Consumption by Country (2017-2022)
-
Figure United States Medicine Consumption and Growth Rate (2017-2022)
-
Figure Canada Medicine Consumption and Growth Rate (2017-2022)
-
Figure Mexico Medicine Consumption and Growth Rate (2017-2022)
-
Table Europe Medicine Consumption by Country (2017-2022)
-
Figure Germany Medicine Consumption and Growth Rate (2017-2022)
-
Figure UK Medicine Consumption and Growth Rate (2017-2022)
-
Figure Spain Medicine Consumption and Growth Rate (2017-2022)
-
Figure Belgium Medicine Consumption and Growth Rate (2017-2022)
-
Figure France Medicine Consumption and Growth Rate (2017-2022)
-
Figure Italy Medicine Consumption and Growth Rate (2017-2022)
-
Figure Denmark Medicine Consumption and Growth Rate (2017-2022)
-
Figure Finland Medicine Consumption and Growth Rate (2017-2022)
-
Figure Norway Medicine Consumption and Growth Rate (2017-2022)
-
Figure Sweden Medicine Consumption and Growth Rate (2017-2022)
-
Figure Poland Medicine Consumption and Growth Rate (2017-2022)
-
Figure Russia Medicine Consumption and Growth Rate (2017-2022)
-
Figure Turkey Medicine Consumption and Growth Rate (2017-2022)
-
Table APAC Medicine Consumption by Country (2017-2022)
-
Figure China Medicine Consumption and Growth Rate (2017-2022)
-
Figure Japan Medicine Consumption and Growth Rate (2017-2022)
-
Figure India Medicine Consumption and Growth Rate (2017-2022)
-
Figure South Korea Medicine Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Medicine Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Medicine Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Medicine Consumption and Growth Rate (2017-2022)
-
Figure Thailand Medicine Consumption and Growth Rate (2017-2022)
-
Figure Singapore Medicine Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Medicine Consumption and Growth Rate (2017-2022)
-
Figure Philippines Medicine Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Medicine Consumption and Growth Rate (2017-2022)
-
Table South America Medicine Consumption by Country (2017-2022)
-
Figure Brazil Medicine Consumption and Growth Rate (2017-2022)
-
Figure Colombia Medicine Consumption and Growth Rate (2017-2022)
-
Figure Chile Medicine Consumption and Growth Rate (2017-2022)
-
Figure Argentina Medicine Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Medicine Consumption and Growth Rate (2017-2022)
-
Figure Peru Medicine Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Medicine Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Medicine Consumption and Growth Rate (2017-2022)
-
Table GCC Medicine Consumption by Country (2017-2022)
-
Figure Bahrain Medicine Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Medicine Consumption and Growth Rate (2017-2022)
-
Figure Oman Medicine Consumption and Growth Rate (2017-2022)
-
Figure Qatar Medicine Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Medicine Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Medicine Consumption and Growth Rate (2017-2022)
-
Table Africa Medicine Consumption by Country (2017-2022)
-
Figure Nigeria Medicine Consumption and Growth Rate (2017-2022)
-
Figure South Africa Medicine Consumption and Growth Rate (2017-2022)
-
Figure Egypt Medicine Consumption and Growth Rate (2017-2022)
-
Figure Algeria Medicine Consumption and Growth Rate (2017-2022)
-
Table Oceania Medicine Consumption by Country (2017-2022)
-
Figure Australia Medicine Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Medicine Consumption and Growth Rate (2017-2022)
-
Table Shire Company Details
-
Table Shire Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Shire Medicine Main Business and Markets Served
-
Table Shire Medicine Product Portfolio
-
Table Novartis Company Details
-
Table Novartis Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Medicine Main Business and Markets Served
-
Table Novartis Medicine Product Portfolio
-
Table Gilead Sciences Company Details
-
Table Gilead Sciences Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Gilead Sciences Medicine Main Business and Markets Served
-
Table Gilead Sciences Medicine Product Portfolio
-
Table Bristol-Myers Squibb Company Details
-
Table Bristol-Myers Squibb Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Medicine Main Business and Markets Served
-
Table Bristol-Myers Squibb Medicine Product Portfolio
-
Table Roche Company Details
-
Table Roche Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Medicine Main Business and Markets Served
-
Table Roche Medicine Product Portfolio
-
Table Pfizer Company Details
-
Table Pfizer Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Medicine Main Business and Markets Served
-
Table Pfizer Medicine Product Portfolio
-
Table AstraZeneca Company Details
-
Table AstraZeneca Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Medicine Main Business and Markets Served
-
Table AstraZeneca Medicine Product Portfolio
-
Table AbbVie Company Details
-
Table AbbVie Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
Table AbbVie Medicine Main Business and Markets Served
-
Table AbbVie Medicine Product Portfolio
-
Table Novo Nordisk Company Details
-
Table Novo Nordisk Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novo Nordisk Medicine Main Business and Markets Served
-
Table Novo Nordisk Medicine Product Portfolio
-
Table Bayer Company Details
-
Table Bayer Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer Medicine Main Business and Markets Served
-
Table Bayer Medicine Product Portfolio
-
Table Merck & Co (MSD) Company Details
-
Table Merck & Co (MSD) Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck & Co (MSD) Medicine Main Business and Markets Served
-
Table Merck & Co (MSD) Medicine Product Portfolio
-
Table GlaxoSmithKline (GSK) Company Details
-
Table GlaxoSmithKline (GSK) Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline (GSK) Medicine Main Business and Markets Served
-
Table GlaxoSmithKline (GSK) Medicine Product Portfolio
-
Table Teva Company Details
-
Table Teva Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Medicine Main Business and Markets Served
-
Table Teva Medicine Product Portfolio
-
Table Amgen Company Details
-
Table Amgen Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Medicine Main Business and Markets Served
-
Table Amgen Medicine Product Portfolio
-
Table Eli Lilly Company Details
-
Table Eli Lilly Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly Medicine Main Business and Markets Served
-
Table Eli Lilly Medicine Product Portfolio
-
Table Takeda Company Details
-
Table Takeda Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Takeda Medicine Main Business and Markets Served
-
Table Takeda Medicine Product Portfolio
-
Table Boehringer Ingelheim Company Details
-
Table Boehringer Ingelheim Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Boehringer Ingelheim Medicine Main Business and Markets Served
-
Table Boehringer Ingelheim Medicine Product Portfolio
-
Table Allergan Company Details
-
Table Allergan Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Allergan Medicine Main Business and Markets Served
-
Table Allergan Medicine Product Portfolio
-
Table Sanofi Company Details
-
Table Sanofi Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Medicine Main Business and Markets Served
-
Table Sanofi Medicine Product Portfolio
-
Table Johnson & Johnson Company Details
-
Table Johnson & Johnson Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Medicine Main Business and Markets Served
-
Table Johnson & Johnson Medicine Product Portfolio
-
Figure Global Brand Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Generic Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Medicine Consumption Forecast by Country (2022-2028)
-
Table North America Medicine Consumption Forecast by Country (2022-2028)
-
Figure United States Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Medicine Consumption Forecast by Country (2022-2028)
-
Figure Germany Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Medicine Consumption Forecast by Country (2022-2028)
-
Figure China Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Medicine Consumption Forecast by Country (2022-2028)
-
Figure Brazil Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Medicine Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Medicine Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Medicine Consumption Forecast by Country (2022-2028)
-
Figure Australia Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Medicine Consumption Forecast and Growth Rate (2022-2028)
-
